Streetbeat News

Stock Prices

PLSE

Pulse Biosciences has announced preliminary findings from its first-in-human feasibility study of the CellFX nsPFA 360 Cardiac Catheter. The study's results are crucial for the company's progress in developing this technology for cardiac applications.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:31 pm

CRBP

INTC

TCBI

WVE

Insiders at Wave Life Sciences, Corbus Pharmaceuticals, Intel, and Texas Capital Bancshares have made significant stock purchases. GSK plc, a 10% owner of Wave Life Sciences, acquired 3.3 million shares for $16.5 million following an upgrade by Leerink Partners with a $12 price target. Bihua Chen, a 10% owner of Corbus Pharmaceuticals, bought shares worth $9.11 million amid a public offering announcement. Intel's CEO Patrick Gelsinger purchased shares for $130,083 after the company issued lower-than-expected guidance. Robert Stallings, a director at Texas Capital Bancshares, bought shares for $194,890 following disappointing earnings.

Portfolio Pulse from Avi Kapoor

January 31, 2024 | 1:31 pm

SBUX

Starbucks' stock (SBUX) is trading higher following the release of their Q1 financial results, indicating a positive market reaction to the company's performance.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:30 pm

GOOG

GOOGL

Alphabet's stock is trading lower following the release of their Q4 financial results, indicating that the results may have not met investor expectations.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:30 pm

SYK

Stryker Corporation's stock is trading higher following the announcement of their fourth-quarter financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:29 pm

EWG

Germany's Consumer Price Index (CPI) for January showed a month-on-month increase of 0.2%, which was in line with the market estimates and slightly higher than the previous month's increase of 0.1%.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:28 pm

UPS

Raymond James analyst Patrick Tyler Brown has maintained a Strong Buy rating on United Parcel Service (UPS) but has reduced the price target from $185 to $175.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:27 pm

PETV

PetVivo Holdings has published the results of a clinical study on the tolerance of dogs to intra-articular injections of Spryng with OsteoCushion Technology. The study is significant for veterinarians and pet owners considering treatment options for canine joint issues.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:25 pm

CRBP

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) shares rose over 35% to close at $25.16 on Tuesday and are trading higher in premarket on Wednesday. The company announced plans for an underwritten registered public offering of common stock or pre-funded warrants. The proceeds will fund clinical development and for general corporate purposes. Data from a clinical study of CRB-701 was presented at a symposium, and Point72 Capital Advisors disclosed an 8.8% passive stake in Corbus. Oppenheimer analyst Jeff Jones maintained an Outperform rating and raised the price target to $51 from $20.

Portfolio Pulse from Nabaparna Bhattacharya

January 31, 2024 | 1:25 pm

GOOG

Susquehanna analyst Shyam Patil has maintained a Positive rating on Alphabet Inc. (NASDAQ:GOOG) and increased the price target from $150 to $170, indicating a bullish outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:22 pm